AI-generated analysis. Always verify with the original filing.
IceCure Medical Ltd announced the appointment of Meir Peleg as Chief Financial Officer effective May 17, 2026, amid strong commercial momentum for ProSense®. The company also disclosed the resignation of Naum Muchnik as Vice President of R&D and Engineering effective April 12, 2026, with no disagreement on operations, and plans to appoint Dr. Richard Fine as Medical Director in Q2 2026 while searching for a new Chief Technology Officer.
Event Type
Disclosure
Voluntary
Variant
6-K
Current Report on Form 6-K
Meir Peleg
Effective: 2026-05-17
Naum Muchnik
Effective: 2026-04-12
not related to any disagreement with the Company on any matter relating to its operations, policies or practices
Richard E. Fine, MD, FACS
Effective: Q2 2026